Aurobindo gets FDA OK for generic Bystolic
Nebivolol tablets have a market value of roughly $978 million for the 12 months ending October 2021, according to IQVIA.
Aurobindo has received The Food and Drug Administration’s blessing for nebivolol tablets, in dosage strengths of 2.5 mg, 5 mg, 10 mg and 20 mg.
The product is the generic of Allergan Sales’ Bystolic. It is indicated for the treatment of hypertension.
[Read more: Aurobindo obtains FDA OK for generic Lioresal]
Nebivolol tablets have a market value of roughly $978 million for the 12 months ending October 2021, according to IQVIA.